What's breaking now, across thousands of outlets.
Oppenheimer raised Viking Therapeutics' price target to $120, citing strong trial data, and an improving probability of success for its key drug.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
U.S. private equity—with more than $3 trillion in assets under management—has been locked in a cycle of geopolitical uncertainty and possible rate hikes.
Bitcoin and gold hold steady as a firm dollar and rising bond yields weigh on sentiment, while IREN secures a multiyear cloud services deal with Anthropic.
Die steigenden Anleiherenditen machen die Baukosten hierzulande deutlich teurer. In den Vereinigten Staaten ist die Belastung sogar noch höher.
STOCKHOLM — American-born economists Robert E. Hall and Michael Woodford won the Nobel memorial prize in economics on Monday for their work on models that have helped governments and central banks…
The Reserve Bank has launched the 116th round of the quarterly Industrial Outlook Survey (IOS) of the Indian manufacturing sector for the reference period October-December 2026.
The Reserve Bank has launched the 51st round of the quarterly Services and Infrastructure Outlook Survey (SIOS) for the reference period October-December 2026.
